Chemical genetic profiling of the microtubule-targeting agent peloruside A in budding yeast Saccharomyces cerevisiae

Gene

Volumn 497, Issue 2, 2012, Pages 140-146

  Wilmes, Anja ^a   Hanna, Reem ^a   Heathcott, Rosemary W ^a   Northcote, Peter T ^a   Atkinson, Paul H ^a   Bellows, David S ^a   Miller, John H ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Chemical genetics; MAD2; Paclitaxel; Peloruside; Saccharomyces cerevisiae; Yeast

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; PELORUSIDE A; PROTEIN MAD1; PROTEIN MAD2; TAXOID; TUBULIN; UNCLASSIFIED DRUG;

ANAPHASE; ARTICLE; DRUG BINDING SITE; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; HAPLOID SPORE; IC 50; MEMBRANE TRANSPORT; MICROARRAY ANALYSIS; MITOSIS; MITOSIS SPINDLE; PRIORITY JOURNAL; RNA SPLICING; SACCHAROMYCES CEREVISIAE; SENSITIVITY ANALYSIS;

BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; BIOLOGICAL TRANSPORT; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HOMOZYGOTE; LACTONES; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; NUCLEAR PROTEINS; PACLITAXEL; RNA SPLICING; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SACCHAROMYCETALES; SEQUENCE DELETION; TUBULIN;

MAMMALIA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 84862829651     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.072     Document Type: Article

References (35)

1. Barnes G., Louie K.A., Botstein D. Yeast proteins associated with microtubules in vitro and in vivo. Mol. Biol. Cell 1992, 3:29-47.
2. Berlin V., Styles C.A., Fink G.R. BIK1, a protein required for microtubule function during mating and mitosis in Saccharomyces cerevisiae, colocalizes with tubulin. J. Cell Biol. 1990, 111:2573-2586.
3. Bode C.J., Gupta M.L., Reiff E.A., Suprenant K.A., Georg G.I., Himes R.H. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules. Biochemistry 2002, 41:3870-3874.
4. Deutschbauer A.M., et al. Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 2005, 169:1915-1925.
5. Foland T.B., Dentler W.L., Suprenant K.A., Gupta M.L., Himes R.H. Paclitaxel-induced microtubule stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of Saccharomyces cerevisiae. Yeast 2005, 22:971-978.
6. Gaber R.F., Copple D.M., Kennedy B.K., Vidal M., Bard M. The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol. Cell. Biol. 1989, 9:3447-3456.
7. Gaitanos T.N., et al. Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res. 2004, 64:5063-5067.
8. Giaever G., et al. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 1999, 21:278-283.
9. Giaever G., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002, 418:387-391.
10. Giaever G., et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:793-798.
11. Gupta M.L., Bode C.L., Georg G.L., Himes R.H. Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6394-6397.
12. Hardwick K.G., Murray A.W. Mad1p, a phosphoprotein component of the spindle assembly checkpoint in budding yeast. J. Cell Biol. 1995, 131:709-720.
13. Hood K.A., et al. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res. 2002, 62:3356-3360.
14. Huzil J.T., et al. A unique mode of microtubule stabilization induced by Peloruside A. J. Mol. Biol. 2008, 378:1016-1030. 31.
15. Ikui A.E., Yang C.P.H., Matsumoto T., Horwitz S.B. Low concentrations of Taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle 2005, 4:1385-1388.
16. Jungwirt H., Kuchler K. Yeast ABC transporters - a tale of sex, stress, drugs and aging. FEBS Lett. 2006, 580:1131-1138.
17. Kanakkanthara A., et al. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes. Mol. Cancer Ther. 2011, 10:1419-1429.
18. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996, 274:246-248.
19. Li R., Murray A.W. Feedback control of mitosis in budding yeast. Cell 1991, 66:519-531.
20. Lum P.Y., et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004, 116:121-137.
21. Mager W.H., Winderickx J. Yeast as a model for medical and medicinal research. Trends Pharmacol. Sci. 2005, 26:265-273.
22. Menacho-Marquez M., Murguia J.R. Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research. Clin. Transl. Oncol. 2007, 9:221-228.
23. 3H]peloruside A. J. Chem. Inf. Model. 2010, 50:2019-2028.
24. Nislow C., Giaever G. Chemical genomic tools for understanding gene function and drug action. Meth. Microbiol. 2007, 36:387-414.
25. Novick P., Osmond B.C., Botstein D. Suppressors of yeast actin mutations. Genetics 1989, 121:659-674.
26. Parekh H., Wiesen K., Simpkins H. Acquisition of Taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochem. Pharmacol. 1997, 53:461-470.
27. Parsons A.B., et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 2004, 22:62-69.
28. Parsons A.B., et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006, 126:611-625.
29. Pierce S.E., Davis R.W., Nislow C., Giaever G. Genome-wide analysis of barcoded Saccharomyces cerevisiae gene-deletion mutants in pooled cultures. Nat. Protoc. 2007, 2:2958-2974.
30. Schatz P.J., Solomon F., Botstein D. Genetically essential and nonessential α-tubulin genes specify functionally interchangeable proteins. Mol. Cell. Biol. 1986, 6:3722-3733.
31. West L.M., Northcote P.T., Battershill C.N. Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand sponge Mycale sp. J. Org. Chem. 2000, 65:445-449.
32. Whitehurst A.W., et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007, 446:815-819.
33. Wilmes A., et al. Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells. Invest. New Drugs 2011, 29:544-553.
34. Wilmes A., Chan A., Rawson P., Jordan T.W., Miller J.H. Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A. Invest. New Drugs 2012, 30:121-129.
35. Winzeler E.A., et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999, 285:901-906.